Arcaro, Alexandre (2014). Targeting PI3K/mTOR Signaling in Cancer. Frontiers in oncology, 4, p. 84. Frontiers Research Foundation 10.3389/fonc.2014.00084
|
Text
Paper 4 Arcaro.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (363kB) | Preview |
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hämatologie / Onkologie (Pädiatrie) 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hämatologie / Onkologie (Pädiatrie) |
UniBE Contributor: |
Arcaro, Alexandre |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2234-943X |
Publisher: |
Frontiers Research Foundation |
Language: |
English |
Submitter: |
Anette van Dorland |
Date Deposited: |
05 Feb 2015 11:50 |
Last Modified: |
05 Dec 2022 14:39 |
Publisher DOI: |
10.3389/fonc.2014.00084 |
PubMed ID: |
24795861 |
Uncontrolled Keywords: |
Akt, cancer, clinical trials, mTOR, phosphoinositide 3-kinase |
BORIS DOI: |
10.7892/boris.62498 |
URI: |
https://boris.unibe.ch/id/eprint/62498 |
Actions (login required)
 |
Edit item |